DNA Genotek, a leading provider of products for biological sample collection, today announced that Tepnel Pharmaceutical Services will offer Oragene•DNA sample collection kits as part of its nucleic acid extraction and genotyping service.

Ottawa, ON (PRWEB) — DNA Genotek (http://www.dnagenotek.com/), a leading provider of products for biological sample collection, today announced that Tepnel Pharmaceutical Services (http://www.tepnel.com/pharmaceutical-services.asp)will offer Oragene•DNA (http://www.dnagenotek.com/DNA_Genotek_Product_Oragene_DNA_A_Overview.html)sample collection kits as part of its nucleic acid extraction and genotyping service. Tepnel Pharmaceutical Services can now offer full end-to-end service packages that combine DNA sample collection, extraction and genetic analysis from saliva.

Tepnel Pharmaceutical Services is an established business of Gen-Probe Incorporated, a world leader in molecular diagnostics.

The integration of Oragene•DNA into Tepnel Pharmaceutical Services’ offering provides its clients access to easy, reliable and non-invasive self-collection of saliva samples. This saves researchers time and expense, and enables them to conduct studies that would otherwise not be feasible, ultimately augmenting the potential to uncover the cause or treatment for a specific disease.

As part of this relationship, Tepnel Pharmaceutical Services has joined the DNA Genotek Partner Program (http://www.dnagenotek.com/DNA_Genotek_Partners_Overview.html). This means that Tepnel Pharmaceutical Services has validated Oragene•DNA kits for use within its nucleic acid extraction and genotyping service, which includes sample quantification and normalization; whole genome amplification; singleplex and array-based genotyping, expression analysis and sample archiving.

“Expanding our service portfolio with Oragene•DNA was a natural progression for us, as we strive to consistently provide high quality services on industry leading platforms in order to satisfy our clients’ needs,” said Dr Allan Brown, Managing Director, Gen-Probe Life Sciences Ltd., “We can now offer a reliable and comprehensive end-to-end solution for DNA collection, extraction and genotyping from saliva. This system also provides a very cost-effective option for clients who are looking for complete contract research services.”

“Tepnel Pharmaceutical Services is one of Europe’s leading service providers within the pharmaceutical sector, and consistently demonstrates a high level of expertise and innovation in genomic research,” said Ian Curry, President and CEO, DNA Genotek, Inc. “We are proud to welcome them onto our Partner Program, allowing us to help connect customers with an approved service provider to reliably process samples collected with our products.”

For more information on Oragene•DNA, please visit www.dnagenotek.com or email us at [email protected].

About DNA Genotek:

DNA Genotek focuses on providing high-quality biological sample collection products. The company’s lead product, the Oragene•DNA Self-Collection Kit, is the easiest way to collect and preserve large amounts of DNA from saliva. Oragene•DNA’s reliability and ease-of-use have resulted in rapid adoption at top-tier health research institutions globally, including Harvard, Stanford, Cambridge, and Johns Hopkins. DNA Genotek markets its products worldwide and has established a global customer base in over 85 countries. For more information about DNA Genotek, visit www.dnagenotek.com

About Tepnel Pharmaceutical Services

Tepnel Pharmaceutical Services offers a comprehensive range of regulatory compliant, outsourced services including biomanufacturing support, cGMP drug development, bioanalysis and molecular genetic services. Its state-of-the-art laboratories and analytical platforms support a broad spectrum of techniques while its quality assurance system facilitates individual accountability of every sample.

About Gen-Probe

Gen-Probe Incorporated is a global leader in the development, manufacture and marketing of rapid, accurate and cost-effective nucleic acid tests (NATs) that are used primarily to diagnose human diseases and screen donated human blood. Gen-Probe has more than 25 years of NAT expertise, and received the 2004 National Medal of Technology, America’s highest honor for technological innovation, for developing NAT assays for blood screening. Gen-Probe is headquartered in San Diego and employs approximately 1,200 people.

For more information, go to www.gen-probe.com.

® Oragene is a registered trademark of DNA Genotek, Inc.